ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Risk Reward Update

Published: 2026-07-31Institution: Morgan StanleyCompany / ticker: JARD.SIPages: 9Original language: English

First-page research excerpt

Not for redistribution without written consent of Morgan Stanley

M

Update

July 31, 2026 04:24 PM GMT

Jardine Matheson Holdings Limited | Asia Pacific

Morgan Stanley Asia Limited+

Dan Chee

Equity Analyst

Risk Reward Update

What’s Changed

Updated Components

EPS

Risks to Price Target / Rating

Jardine Matheson Holdings Limited (JARD.SI, JM SP)

Risk Reward for Jardine Matheson Holdings Limited (JARD.SI) has

been updated

Reason for change

• We updated the definition of "underlying profit" based on the company's

latest adjustments to remove disposals and to remove the contribution from

Zhongsheng.

• As a result, we removed a previously projected US$63mn Zhongsheng

contribution in each of the years in FY26/27/28E.

Hong Kong/China Multi-Industry | Hong Kong

Stock Rating

Industry View

Price target

Shr price, close (Jul 31, 2026)

52-Week Range

Fiscal Year Ending

EPS (US$)**

Prior EPS (US$)**

Overweight

In-Line

US$80.00

US$66.41

US$82.50-54.53

12/25 12/26e 12/27e 12/28e

5.72

5.48

5.67

5.76

5.85

5.99

Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare

framework

** = Based on consensus methodology

e = Morgan Stanley Research estimates

• This resulted in a 3% cut to our FY26e EPS while keeping other operating

assumptions unchanged.

• We increased our projected profit contribution from Jardine Pacific by ~25%

in FY27/28e, as the company expects its Engineering business to double

earnings by 2030. The net result for FY27/28e EPS changes is -2%/flat,

respectively

• No change in price target or bull/bear scenarios.

Morgan Stanley does and seeks to do business with

companies covered in Morgan Stanley Research. As a result,

investors should be aware that the firm may have a conflict of

interest that could affect the objectivity of Morgan Stanley

Research. Investors should consider Morgan Stanley

Research as only a single factor in making their investment

decision.

The excerpt is extracted automatically from page one and may contain layout or recognition errors. Sign in to review access options.

Open report viewer